News Digest / Ticker: BIIB

Ticker: BIIB

07:09am, Thursday, Jul 31, 2025

Biogen Reports 7.3% Revenue Growth Amid Challenges from Competition and Rising Costs

Company Overview Biogen Inc. (NASDAQ: BIIB) is a leading biopharmaceutical company focused on making innovative therapies for serious diseases including Multiple Sclerosis (MS), Spinal Muscular Atrophy (SMA), and Alzheimer's. The company's revenues and operations are significantly impacted by the...

05:03pm, Thursday, May 01, 2025

Biogen Reports Q1 2025 Revenue Growth Amid Declining Income and MS Challenges

04:53am, Wednesday, Jul 03, 2024

Eli Lilly's New Alzheimer's Drug Kisunla Gets FDA Approval, Projected to Earn $5 Billion Annually